Brief Cognitive Behavioral Therapy Via Telehealth Cuts Suicide Attempts
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 15, 2024 -- Brief cognitive behavioral therapy (BCBT) delivered via video telehealth is effective for reducing suicide attempts among adults with recent suicidal thoughts and/or behaviors, according to a study published online Nov. 12 in JAMA Network Open.
Justin C. Baker, Ph.D., from The Ohio State University in Columbus, and colleagues tested the efficacy of BCBT delivered via video telehealth for reducing suicide attempts and suicidal ideation among high-risk adults. Analysis included 96 adults randomly assigned to either BCBT or present-centered therapy (PCT).
The researchers found that from baseline to 12 months, 12 of 45 participants receiving PCT made 56 suicide attempts versus 11 of 51 participants receiving BCBT who made 36 suicide attempts. Significantly fewer suicide attempts were made among participants receiving BCBT versus PCT (mean, 0.70 attempts per participant versus 1.40 per participant), yielding a lower risk for suicide attempts (hazard ratio, 0.59). In both groups, severity of suicidal ideation significantly decreased, but there was no significant difference between the groups.
"To our knowledge, this study is the first study to demonstrate that individuals at high risk of suicide can be safely and effectively treated via telehealth, which has implications for increasing access to care, while maintaining treatment fidelity with established evidence-based treatments," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-17 00:00
Read more
- Sleep Apnea Could Raise Dementia Risk, Especially for Women
- Total Hip Replacement Revision Rates Vary With Type of Material Used
- COVID-19 Burden in Hospitals Affects Risk for In-Hospital Adverse Events
- Racial, Ethnic Differences Seen in Cleft Lip Surgery Repair
- Exercise Cuts Dependence in Those With Alcohol Use Disorder
- AAO: Wastage Seen With Artificial Expiration of Eye Drops in Ophthalmic Clinics
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions